1. Home
  2. RYM vs LNSR Comparison

RYM vs LNSR Comparison

Compare RYM & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYM

RYTHM Inc.

HOLD

Current Price

$21.28

Market Cap

60.2M

ML Signal

HOLD

Logo LENSAR Inc.

LNSR

LENSAR Inc.

N/A

Current Price

$5.76

Market Cap

69.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RYM
LNSR
Founded
2016
2004
Country
United States
United States
Employees
141
N/A
Industry
Farming/Seeds/Milling
Medical Electronics
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
69.1M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
RYM
LNSR
Price
$21.28
$5.76
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
8.7K
110.0K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$58,435,000.00
Revenue This Year
N/A
$10.06
Revenue Next Year
N/A
$41.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.24
52 Week Low
$14.00
$5.06
52 Week High
$53.65
$13.32

Technical Indicators

Market Signals
Indicator
RYM
LNSR
Relative Strength Index (RSI) 38.17 46.81
Support Level $20.76 $5.58
Resistance Level $28.48 $6.20
Average True Range (ATR) 1.05 0.24
MACD -0.16 -0.03
Stochastic Oscillator 21.73 13.44

Price Performance

Historical Comparison
RYM
LNSR

About RYM RYTHM Inc.

Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.

About LNSR LENSAR Inc.

LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.

Share on Social Networks: